Get the Stockscreener App
7.8323
3.42%
-0.2777
After Hours:
7.83
-0.0023
-0.03%
Sensei Biotherapeutics Inc stock is traded at $7.8323, with a volume of 10,568.
It is down -3.42% in the last 24 hours and up +12.21% over the past month.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).
See More
Previous Close:
$8.11
Open:
$8.43
24h Volume:
10,568
Relative Volume:
0.65
Market Cap:
$9.88M
Revenue:
-
Net Income/Loss:
$-29.80M
P/E Ratio:
-6.5818
EPS:
-1.19
Net Cash Flow:
$-25.19M
1W Performance:
-1.85%
1M Performance:
+12.21%
6M Performance:
-13.53%
1Y Performance:
-37.73%
1-Day Range:
$7.8323
$8.70
1-Week Range:
$7.21
$8.70
52-Week Range:
$5.00
$17.40
Sensei Biotherapeutics Inc Stock (SNSE) Company Profile
Name
Sensei Biotherapeutics Inc
Sector
Industry
Phone
(240) 243-8000
Address
1405 RESEARCH BLVD, SUITE 125, ROCKVILLE
Compare SNSE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SNSE
Sensei Biotherapeutics Inc
|
7.8323 | 10.43M | 0 | -29.80M | -25.19M | -1.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.18 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
587.65 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.20 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
708.09 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
308.91 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Sensei Biotherapeutics Inc Stock (SNSE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Resumed | H.C. Wainwright | Buy |
| May-14-24 | Initiated | Stephens | Overweight |
| Jul-01-21 | Downgrade | Berenberg | Buy → Hold |
| Jun-29-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Mar-01-21 | Initiated | Berenberg | Buy |
| Mar-01-21 | Initiated | Citigroup | Buy |
| Mar-01-21 | Initiated | Oppenheimer | Outperform |
| Mar-01-21 | Initiated | Piper Sandler | Overweight |
View All
Sensei Biotherapeutics Inc Stock (SNSE) Latest News
Top chart patterns to watch in Sensei Biotherapeutics Inc.Weekly Profit Report & Weekly Breakout Opportunity Watchlist - Newser
How hedge fund analytics apply to Sensei Biotherapeutics Inc. stockWeekly Stock Report & Daily Oversold Bounce Ideas - Newser
What Fibonacci levels say about Sensei Biotherapeutics Inc. reboundStock Surge & Risk Managed Investment Strategies - Newser
Real time alert setup for Sensei Biotherapeutics Inc. performanceWeekly Trade Review & Reliable Trade Execution Plans - Newser
Sensei Biotherapeutics Inc. stock momentum explainedJuly 2025 Chart Watch & Daily Market Momentum Tracking - Newser
Can Sensei Biotherapeutics Inc. rally from current levelsWeekly Investment Summary & Expert Approved Trade Ideas - Newser
Price action breakdown for Sensei Biotherapeutics Inc.July 2025 Short Interest & Capital Efficiency Focused Strategies - Newser
Will earnings trigger a reversal in Sensei Biotherapeutics Inc.2025 Key Lessons & Growth Focused Entry Reports - Newser
Ranking Sensei Biotherapeutics Inc. among high performing stocks via toolsEarnings Overview Summary & Accurate Buy Signal Notifications - Newser
Short Term Trend Reversal in Sensei Biotherapeutics Inc. PossibleLong Setup & High Conviction Trade Alerts - Newser
Applying Wyckoff theory to Sensei Biotherapeutics Inc. stockWatch List & Daily Entry Point Trade Alerts - Newser
Can you recover from losses in Sensei Biotherapeutics Inc.Market Weekly Review & Safe Entry Momentum Tips - Newser
Using data tools to time your Sensei Biotherapeutics Inc. exitJuly 2025 Trends & Community Verified Trade Signals - Newser
Key metrics from Sensei Biotherapeutics Inc.’s quarterly dataPrice Action & Weekly High Return Forecasts - Newser
Smart tools for monitoring Sensei Biotherapeutics Inc.’s price actionEarnings Trend Report & High Conviction Investment Ideas - Newser
Published on: 2025-08-16 06:29:30 - Newser
Regression analysis insights on Sensei Biotherapeutics Inc. performanceQuarterly Trade Report & AI Driven Stock Movement Reports - Newser
How to manage a losing position in Sensei Biotherapeutics Inc.Market Trend Report & AI Driven Price Forecasts - Newser
Tick level data insight on Sensei Biotherapeutics Inc. volatilityMarket Growth Summary & Risk Managed Trade Strategies - Newser
Sensei Biotherapeutics Inc.’s volatility index tracking explained2025 Price Action Summary & Safe Swing Trade Setup Alerts - Newser
Using RSI to spot recovery in Sensei Biotherapeutics Inc.GDP Growth & Stock Portfolio Risk Control - Newser
Sensei Biotherapeutics Inc. Charts Flash Early Recovery SignalsJuly 2025 PostEarnings & Technical Buy Zone Confirmation - beatles.ru
Sensei Biotherapeutics Trading Halted Due to Volatility - AInvest
Sensei Biotherapeutics Skyrockets 19.87%—What’s Fueling This Biotech Breakout? - AInvest
Sensei Biotherapeutics (SNSE) Stock Price, News & Analysis - MarketBeat
Is Sensei Biotherapeutics Inc. stock trending bullishFed Meeting & Free Expert Approved Momentum Trade Ideas - sundaytimes.kr
What momentum shifts mean for Sensei Biotherapeutics Inc.Quarterly Profit Report & High Conviction Buy Zone Alerts - Newser
Is Sensei Biotherapeutics Inc. stock overhyped or has real potentialStock Portfolio Risk and Return Analysis - Newser
Short interest data insights for Sensei Biotherapeutics Inc.Free Weekly Stock Opportunity Radar Scanner - Newser
What institutions are buying Sensei Biotherapeutics Inc. stock nowDeep Learning Stock Forecast for Investors - Newser
Sensei Biotherapeutics Inc Stock (SNSE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.95%
0.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):